Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Emmanuel Zachariah, PhD"'
Autor:
Jyoti Malhotra, MD, MPH, Yong Lin, PhD, Malini Patel, MD, Michael J. Yellin, MD, Emmanuel Zachariah, PhD, Curtis Krier, PhD, Ankit Saxena, PhD, Salma K. Jabbour, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 8, Pp 100687- (2024)
Introduction: Anti-programmed cell death 1 (PD-1) immunotherapy is the standard of care for metastatic NSCLC but many tumors develop resistance. We hypothesized that combining a T-cell agonist such as varlilumab (anti-CD27 antibody) with checkpoint i
Externí odkaz:
https://doaj.org/article/45d701c3f47f4b6992025ff4c2b551a4
Publikováno v:
Immunotherapy Weekly; 8/13/2024, p2329-2329, 1p